Demographic and follow-up characteristics of the study cohort
| Characteristic . | Count . | % . | n* . |
|---|---|---|---|
| Male | 79 | 51.6 | 153 |
| Female | 74 | 48.4 | 153 |
| Lilongwe District | 120 | 90.2 | 133 |
| Lost to follow-up (after 12 months) | 54 | 34.4 | 157 |
| Deceased | 6 | 3.8 | 157 |
| HbSS | 155 | 98.7 | 157 |
| HbSc | 1 | 0.6 | 157 |
| HbFS | 1 | 0.6 | 157 |
| Median | Range or IQR | n* | |
| Age at enrollment, years | 7 | Range, 0-20 | 148 |
| Duration of follow-up, months | 27 | IQR, 24-36 | 135 |
| No. of follow-up study visits | 3 | IQR, 2-4 | 157 |
| Characteristic . | Count . | % . | n* . |
|---|---|---|---|
| Male | 79 | 51.6 | 153 |
| Female | 74 | 48.4 | 153 |
| Lilongwe District | 120 | 90.2 | 133 |
| Lost to follow-up (after 12 months) | 54 | 34.4 | 157 |
| Deceased | 6 | 3.8 | 157 |
| HbSS | 155 | 98.7 | 157 |
| HbSc | 1 | 0.6 | 157 |
| HbFS | 1 | 0.6 | 157 |
| Median | Range or IQR | n* | |
| Age at enrollment, years | 7 | Range, 0-20 | 148 |
| Duration of follow-up, months | 27 | IQR, 24-36 | 135 |
| No. of follow-up study visits | 3 | IQR, 2-4 | 157 |
HbFS, fetal hemoglobin sickle cell; HbSc, sickle cell hemoglobin C; HbSS, homozygous sickle cell; IQR, interquartile range.
n represents total number of patients in the subgroup.